Week Ending May 31st, 2024:
Biotech: 4 Transactions (3 Follow-Ons and 1 PIPE) totaling just under $1.4 Billion
Med Tech: 1 Transaction (1 Follow-On) totaling just over $400 Million
2024 YTD:
156 Biotech transactions totaling just under $27 Billion v. 2023 YTD: 66 Biotech transactions totaling just over $9 Billion
7 Med Tech transactions totaling just over $1 Billion v. 2023 YTD: 6 Med Tech transactions totaling just over $400 Million
Private Transactions:
Biotech: 112 US Transactions / 45 European Transactions
Med Tech: 58 US Transactions / 26 European Transactions
May Transactions:
Merck acquired EyeBio for $1.3B
Johnson & Johnson acquired Yellow Jersey Therapeutics for $1.25B
Asahi Kasei acquired Calliditas Therapeutics for $1.1B or $19.54/share
Biogen acquired Hl-Bio for $1.15B
J&J acquired Proteologix for $850M
Novartis acquired Mariana Oncology for $1B
Comments